152 related articles for article (PubMed ID: 31051372)
1. MRI-based tumour control probability in skull-base chordomas treated with carbon-ion therapy.
Buizza G; Molinelli S; D'Ippolito E; Fontana G; Pella A; Valvo F; Preda L; Orecchia R; Baroni G; Paganelli C
Radiother Oncol; 2019 Aug; 137():32-37. PubMed ID: 31051372
[TBL] [Abstract][Full Text] [Related]
2. Microstructural parameters from DW-MRI for tumour characterization and local recurrence prediction in particle therapy of skull-base chordoma.
Morelli L; Palombo M; Buizza G; Riva G; Pella A; Fontana G; Imparato S; Iannalfi A; Orlandi E; Paganelli C; Baroni G
Med Phys; 2023 May; 50(5):2900-2913. PubMed ID: 36602230
[TBL] [Abstract][Full Text] [Related]
3. Predictive role of Apparent Diffusion Coefficient (ADC) from Diffusion Weighted MRI in patients with sacral chordoma treated with carbon ion radiotherapy (CIRT) alone.
Preda L; Casale S; Fanizza M; Fiore MR; Viselner G; Paganelli C; Buizza G; Fontana G; Vitolo V; Barcellini A; Baroni G; Fossati P; Valvo F
Eur J Radiol; 2020 May; 126():108933. PubMed ID: 32171109
[TBL] [Abstract][Full Text] [Related]
4. RBE-weighted doses in target volumes of chordoma and chondrosarcoma patients treated with carbon ion radiotherapy: Comparison of local effect models I and IV.
Gillmann C; Jäkel O; Karger CP
Radiother Oncol; 2019 Dec; 141():234-238. PubMed ID: 31522880
[TBL] [Abstract][Full Text] [Related]
5. Proton and carbon ion radiotherapy in skull base chordomas: a prospective study based on a dual particle and a patient-customized treatment strategy.
Iannalfi A; D'Ippolito E; Riva G; Molinelli S; Gandini S; Viselner G; Fiore MR; Vischioni B; Vitolo V; Bonora M; Ronchi S; Petrucci R; Barcellini A; Mirandola A; Russo S; Vai A; Mastella E; Magro G; Maestri D; Ciocca M; Preda L; Valvo F; Orecchia R
Neuro Oncol; 2020 Sep; 22(9):1348-1358. PubMed ID: 32193546
[TBL] [Abstract][Full Text] [Related]
6. Temporal lobe reactions after carbon ion radiation therapy: comparison of relative biological effectiveness-weighted tolerance doses predicted by local effect models I and IV.
Gillmann C; Jäkel O; Schlampp I; Karger CP
Int J Radiat Oncol Biol Phys; 2014 Apr; 88(5):1136-41. PubMed ID: 24661667
[TBL] [Abstract][Full Text] [Related]
7. Differentiating skull base chordomas and invasive pituitary adenomas with conventional MRI.
Gao A; Bai J; Cheng J; Cheng X; Li S; Zhang Z; Zhang Y
Acta Radiol; 2018 Nov; 59(11):1358-1364. PubMed ID: 29448805
[TBL] [Abstract][Full Text] [Related]
8. MRI evaluation of sacral chordoma treated with carbon ion radiotherapy alone.
Preda L; Stoppa D; Fiore MR; Fontana G; Camisa S; Sacchi R; Ghitti M; Viselner G; Fossati P; Valvo F; Vitolo V; Bonora M; Iannalfi A; Vischioni B; Vai A; Mastella E; Baroni G; Orecchia R
Radiother Oncol; 2018 Aug; 128(2):203-208. PubMed ID: 29279241
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic accuracy of DW MR imaging in the differentiation of chordomas and chondrosarcomas of the skull base: A 3.0-T MRI study of 105 cases.
Welzel T; Meyerhof E; Uhl M; Huang K; von Deimling A; Herfarth K; Debus J
Eur J Radiol; 2018 Aug; 105():119-124. PubMed ID: 30017267
[TBL] [Abstract][Full Text] [Related]
10. Cost-Effectiveness of Carbon Ion Radiation Therapy for Skull Base Chordoma Utilizing Long-Term (10-Year) Outcome Data.
Sprave T; Verma V; Sterzing F; Bruckner T; Hees K; Land B; Jäkel O; Herfarth K; Debus J; Uhl M
Anticancer Res; 2018 Aug; 38(8):4853-4858. PubMed ID: 30061259
[TBL] [Abstract][Full Text] [Related]
11. Magnetic resonance imaging signal characteristics associated with prognosis of skull base chordoma after gamma knife radiosurgery.
Hu YS; Lee CC; Wu CA; Lin CJ; Yang HC; Guo WY; Liu KD; Chung WY; Shiau CY; Wu HM
J Neurooncol; 2023 Jan; 161(1):45-56. PubMed ID: 36565364
[TBL] [Abstract][Full Text] [Related]
12. Carbon ion radiotherapy for skull base chordomas and chondrosarcomas: a systematic review and meta-analysis of local control, survival, and toxicity outcomes.
Lu VM; O'Connor KP; Mahajan A; Carlson ML; Van Gompel JJ
J Neurooncol; 2020 May; 147(3):503-513. PubMed ID: 32206977
[TBL] [Abstract][Full Text] [Related]
13. Proton and carbon ion beam treatment with active raster scanning method in 147 patients with skull base chordoma at the Heidelberg Ion Beam Therapy Center-a single-center experience.
Mattke M; Ohlinger M; Bougatf N; Harrabi S; Wolf R; Seidensaal K; Welzel T; Röder F; Gerum S; Ellerbrock M; Jäkel O; Haberer T; Herfarth K; Uhl M; Debus J
Strahlenther Onkol; 2023 Feb; 199(2):160-168. PubMed ID: 36149438
[TBL] [Abstract][Full Text] [Related]
14. Analysis of tumour microstructure estimation from conventional diffusion MRI and application to skull-base chordoma
Morelli L; Buizza G; Palombo M; Riva G; Fontana G; Imparato S; Iannalfi A; Orlandi E; Paganelli C; Baroni G
Annu Int Conf IEEE Eng Med Biol Soc; 2021 Nov; 2021():3761-3764. PubMed ID: 34892054
[TBL] [Abstract][Full Text] [Related]
15. Dose-response curves for MRI-detected radiation-induced temporal lobe reactions in patients after proton and carbon ion therapy: Does the same RBE-weighted dose lead to the same biological effect?
Gillmann C; Lomax AJ; Weber DC; Jäkel O; Karger CP
Radiother Oncol; 2018 Jul; 128(1):109-114. PubMed ID: 29459152
[TBL] [Abstract][Full Text] [Related]
16. Long-term outcomes of skull base chordoma treated with high-dose carbon-ion radiotherapy.
Koto M; Ikawa H; Kaneko T; Hagiwara Y; Hayashi K; Tsuji H
Head Neck; 2020 Sep; 42(9):2607-2613. PubMed ID: 32472716
[TBL] [Abstract][Full Text] [Related]
17. Assessment of RBE-Weighted Dose Models for Carbon Ion Therapy Toward Modernization of Clinical Practice at HIT: In Vitro, in Vivo, and in Patients.
Mein S; Klein C; Kopp B; Magro G; Harrabi S; Karger CP; Haberer T; Debus J; Abdollahi A; Dokic I; Mairani A
Int J Radiat Oncol Biol Phys; 2020 Nov; 108(3):779-791. PubMed ID: 32504659
[TBL] [Abstract][Full Text] [Related]
18. Results of carbon ion radiotherapy in 152 patients.
Schulz-Ertner D; Nikoghosyan A; Thilmann C; Haberer T; Jäkel O; Karger C; Kraft G; Wannenmacher M; Debus J
Int J Radiat Oncol Biol Phys; 2004 Feb; 58(2):631-40. PubMed ID: 14751537
[TBL] [Abstract][Full Text] [Related]
19. A step towards international prospective trials in carbon ion radiotherapy: investigation of factors influencing dose distribution in the facilities in operation based on a case of skull base chordoma.
Vogin G; Wambersie A; Koto M; Ohno T; Uhl M; Fossati P; Balosso J;
Radiat Oncol; 2019 Feb; 14(1):24. PubMed ID: 30709366
[TBL] [Abstract][Full Text] [Related]
20. [Carbon ion irradiation of skull base tumors at GSI. First clinical results and future perspectives].
Debus J; Haberer T; Schulz-Ertner D; Jäkel O; Wenz F; Enghardt W; Schlegel W; Kraft G; Wannenmacher M
Strahlenther Onkol; 2000 May; 176(5):211-6. PubMed ID: 10847117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
